{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:08:50Z","timestamp":1791504530096,"version":"4.3.4"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Persistent human papillomavirus infection is an important factor in the development of cervical cancer, which is usually a long process evolving from the development of squamous intraepithelial lesions (SIL), also referred to as cervical intraepithelial neoplasia (CIN). Local treatment of advanced squamous intraepithelial lesions, also regarded as High-Grade Squamous Intraepithelial Lesion, may be effective in preventing cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To promptly identify high-risk patients with a tendency to recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed the clinical data of 300 patients with high-grade squamous intraepithelial lesions of the cervix admitted to the Second Affiliated Hospital of Dalian Medical University from 2019 to 2020 to investigate the relationship between recurrence of cervical lesions and postoperative regression of HPV infection, as well as other related risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We found that the HPV-negative rates were 81.81, 85.71, and 90.91% at 6, 12, and 24\u2009months, respectively, and the average lesion recurrence rate was 8.16%, with a median time to recurrence of 14\u2009months in patients undergoing CKC for HSIL. The risk of cervical squamous intraepithelial lesions was highest in patients with HPV16. Patients over 61\u2009years of age had the lowest postoperative HPV-negative rate. The conversion rate was significantly lower in patients with multiple HPV genotypes than in those with single HPV infection (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05). The probability of recurrence was higher in patients with the same HPV infection genotype before and after surgery than in patients with different infection genotypes before and after surgery (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Combined with the literature review, we believe that patients aged \u226550\u2009years, with \u22653 pregnancies and births, a history of smoking, and consistent genotypes of preoperative and postoperative HPV infection in cervical conization have more HPV re-infection or persistent infection, and that these factors may be high-risk factors for lesion recurrence. For patients with possible potential high-risk factors, we need to carry out individualized follow-up and focused management, take timely and effective management measures, optimize the treatment plan, reduce the recurrence rate, prevent HSIL and cervical cancer, improve the quality of patient\u2019s survival, and improve the prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmicb.2023.1266254","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T03:58:18Z","timestamp":1696564698000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["A study on the correlation between the prognosis of HPV infection and lesion recurrence after cervical conization"],"prefix":"10.3389","volume":"14","author":[{"given":"Junling","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shichao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S1470-2045(17)30700-3","article-title":"Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis","volume":"18","author":"Arbyn","year":"2017","journal-title":"Lancet Oncol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/j.ygyno.2007.08.059","article-title":"Human papillomavirus vaccines and the potential for cross-protection between related HPV types","volume":"107","author":"Ault","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/ijc.23824","article-title":"Post-treatment CIN: randomized clinical trial using hrHPV testing for prediction of residual\/recurrent disease","volume":"124","author":"Bais","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1002\/ijc.23762","article-title":"Prevalence, incidence and clearance of human papillomavirus infection among young primiparous pregnant women in Kampala, Uganda","volume":"123","author":"Banura","year":"2008","journal-title":"Int. J. Cancer"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ijgc-2020-001197","article-title":"Prophylactic human papillomavirus vaccination to prevent recurrence of cervical intraepithelial neoplasia: a meta-analysis","volume":"30","author":"Bartels","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e0217562","DOI":"10.1371\/journal.pone.0217562","article-title":"Menopausal status is associated with a high risk for residual disease after cervical conization with positive margins","volume":"14","author":"Bilibio","year":"2019","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer","volume":"55","author":"Bosch","year":"2002","journal-title":"J. Clin. Pathol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ejca.2009.09.015","article-title":"Cigarette smoking is an inde-pendent risk factor for cervical intraepithelial neoplasia in young women: a longitudinal study","volume":"46","author":"Collins","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2006.10.014","article-title":"Role of hormone cofactors in the human papillomavirus-induced carcinogenesis of the uterine cervix","volume":"264","author":"Delvenne","year":"2007","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3390\/vaccines9050410","article-title":"Adjuvant HPV vaccinationto prevent recurrent cervical dysplasia after surgical treatment: a meta-analysis","volume":"9","author":"Di Donato","year":"2021","journal-title":"Vaccine"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods, and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.virol.2008.10.004","article-title":"Interaction of human papillomaviruses with the host immune system: a well evolved relationship","volume":"384","author":"Frazer","year":"2009","journal-title":"Virology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ygyno.2018.08.033","article-title":"SPERANZA project: HPV vaccination after treatment for CIN2+","volume":"151","author":"Ghelardi","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ygyno.2006.10.011","article-title":"HPV 16 and increased risk of recurrence after treatment for CIN","volume":"104","author":"G\u00f6k","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3390\/v9100267","article-title":"Natural history of HPV infection across the lifespan: role of viral latency","volume":"9","author":"Gravitt","year":"2017","journal-title":"Viruses"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3969\/j.issn.1671-332X.2016.04.008","article-title":"Analysis of factors associated with regression after LEEP treatment for cervical intraepithelial neoplasia","volume":"16","author":"Hui-Qiong","year":"2016","journal-title":"Mod. Hosp."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s10147-011-0322-3","article-title":"Cigarette smoke stimulates VEGF-C expression in cervical intraepithelial neoplasia (CIN) 1 and 2 lesions","volume":"17","author":"Inamine","year":"2012","journal-title":"Int. J. Clin. Oncol."},{"key":"ref18","first-page":"1","volume-title":"Cervix Cancer Screening: IARC Handbooks of Cancer Prevention","year":"2005"},{"key":"ref19","volume-title":"WHO Classification of Tumours: Female Genital Tumours","year":"2020"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/ijc.21493","article-title":"Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies","volume":"118","author":"Appleby","year":"2006","journal-title":"Int. J. Cancer"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/j.ygyno.2008.06.027","article-title":"A review of cross-protection against oncogenic HPV by an HPV-16\/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention","volume":"110","author":"Jenkins","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/bjc.2012.513","article-title":"Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up","volume":"108","author":"Jensen","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"6402","DOI":"10.1016\/j.vaccine.2020.07.055","article-title":"Prophylactic HPV vaccination after conization: a systematic review and meta-analysis","volume":"38","author":"Jentschke","year":"2020","journal-title":"Vaccine"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ygyno.2013.04.050","article-title":"Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)?","volume":"130","author":"Kang","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/GME.0000000000000488","article-title":"Human papillomavirus genotyping as a reliable prognostic marker of recurrence after loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia (CIN2-3) especially in postmenopausal women","volume":"23","author":"Kang","year":"2016","journal-title":"Menopause"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S1470-2045(11)70078-X","article-title":"Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a longterm multi-cohort study","volume":"12","author":"Kocken","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3390\/healthcare7040162","article-title":"The preventive effect of dietary antioxidants against cervical Cancer versus the promotive effect of tobacco smoking","volume":"7","author":"Koshiyama","year":"2019","journal-title":"Health"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1158\/1055-9965.EPI-05-0845","article-title":"Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease","volume":"15","author":"Kreimer","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/LGT.0000000000000260","article-title":"High-grade cervical dysplasia after negative loop electrosurgical excision procedure","volume":"20","author":"Kuroki","year":"2016","journal-title":"J. Low. Genit. Tract Dis."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41416-020-0920-9","article-title":"Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)","volume":"123","author":"Kyrgiou","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1097\/AOG.0000000000003833","article-title":"Adjuvant human papillomavirus vaccine to reduce recurrent cervical dysplasia in unvaccinated women: a systematic review and meta-analysis","volume":"135","author":"Lichter","year":"2020","journal-title":"Obstet. Gynecol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejogrb.2011.11.023","article-title":"Follow-up after LLETZ: a study of 682 cases of CIN-CIN3 in a single institution","volume":"161","author":"Lubrano","year":"2012","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"11164","DOI":"10.1158\/0008-5472.CAN-05-1087","article-title":"Induction of aromatase expression in cervical carcinomas: effects of endogenous estrogen on cervical cancer cell proliferation","volume":"65","author":"Nair","year":"2005","journal-title":"Cancer Res."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3802\/jgo.2009.20.2.91","article-title":"Factors associated with HPV persistence after conization in patients with negative margins","volume":"20","author":"Nam","year":"2009","journal-title":"J. Gynecol. Oncol."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J. Low. Genit. Tract Dis."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.ajog.2006.07.036","article-title":"Subsequent risk and preaentation of cervical intraepithelial neoplasia (CIN3) or cancer after a colposcopic diagnosis of CIN1 or less","volume":"195","author":"Petorius","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ygyno.2021.06.019","article-title":"Predictor factors for conservative management of cervical intraepithelial neoplasia grade 2:cytology and HPV genotyping","volume":"162","author":"Salvad\u00f3","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/ijc.32752","article-title":"Risk of cervical intraepithelial neoplasia grade 2 or worse after conization in relation to HPV vaccination status","volume":"147","author":"Sand","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ijgo.2015.07.026","article-title":"Systematic reviews and meta-analyses of benefits and harms of cryotherapy, LEEP, and cold knife conization to treat cervical intraepithelial neoplasia","volume":"132","author":"Santesso","year":"2016","journal-title":"J. Gynaecol. Obstet."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1089\/jwh.2012.3502","article-title":"Human papillomavirus detection in pregnant women: a prospective matched cohort study","volume":"21","author":"Schmeink","year":"2012","journal-title":"J. Women\u2019s Health (Larchmt)"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/jmv.23806","article-title":"Human papillomavirus type-specific persistence and recurrence after treatment for cervical dysplasia","volume":"86","author":"S\u00f6derlund-Strand","year":"2014","journal-title":"J. Med. Virol."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12884-015-0675-0","article-title":"Risk of human papillomavirus (HPV) infection and cervical neoplasia after pregnancy","volume":"15","author":"Trottier","year":"2015","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ygyno.2014.03.004","article-title":"Recurrent high-grade cervical lesion after primary conization is associated with persistent human papillomavirus infection in Norway","volume":"133","author":"Vintermyr","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J. Pathol."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"030006052211064","DOI":"10.1177\/03000605221106414","article-title":"Modified method of cervical conization with hybrid use of a cold knife and an electric knife for high-grade squamous intraepithelial lesions","volume":"50","author":"Zhang","year":"2022","journal-title":"J. Int. Med. Res."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2023.1266254\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T03:58:22Z","timestamp":1696564702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2023.1266254\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,6]]},"references-count":46,"alternative-id":["10.3389\/fmicb.2023.1266254"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2023.1266254","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,6]]},"article-number":"1266254"}}